Whole transcriptome analysis of peripheral blood mononuclear cells from de novo and drug-naive Parkinson's disease patients
Authors:
Open Access
- 1 October 2025
- journal article
- Published by Elsevier in Neurotherapeutics
- Vol. 22 (6) , e00762
Abstract
No abstract availableKeywords
Funding Information
- Spain Ministry of Education Culture and Sports (FPU22/01375)
- European Regional Development Fund (CIPROM/2023/15)
- State Agency of Research (PID2021-129053OB-100)
- Valencia Department of Education Culture and Sport (CIPROM/2023/15)
- Instituto de Investigación Sanitaria y Biomédica de Alicante
- Fundación Tatiana Pérez de Guzmán el Bueno
- Lady Margaret Hall, University of Oxford
This publication has 67 references indexed in Scilit:
- Human peripheral blood mononuclear cells as a valuable source of disease‐related biomarkers: Evidence from comparative proteomics studiesProteomics – Clinical Applications, 2023
- The immunology of Parkinson’s diseaseSeminars in Immunopathology, 2022
- Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practiceJournal of Neural Transmission, 2022
- Peripheral Immune Profile and Neutrophil‐to‐Lymphocyte Ratio in Parkinson's DiseaseMovement Disorders, 2021
- Increase of Prokineticin‐2 in Serum of Patients with Parkinson's DiseaseMovement Disorders, 2021
- Ten Unsolved Questions About Neuroinflammation in Parkinson's DiseaseMovement Disorders, 2020
- Inhibition of Myc transcriptional activity by a mini‐protein based upon Mxd1FEBS Letters, 2020
- Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyMovement Disorders, 2017
- The anatomical basis of dystonia: Current view using neuroimagingMovement Disorders, 2013
- Peripheral Assessment of the Genes AQP4, PBP and TH in Patients with Parkinson’s DiseaseNeurochemical Research, 2011